首页> 外文期刊>Journal of Cancer Research and Therapeutics >Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma
【24h】

Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma

机译:头颈部鳞状细胞癌中p16表达的评估及临床病理相关性

获取原文
       

摘要

Introduction: Oral squamous cell carcinoma is a major cause of death throughout the developed world. It is associated with smoking and alcohol consumption. Human papillomavirus (HPV) type 16 has also been suggested to play a role in etiology of head and neck squamous cell carcinoma (HNSCC). p16 expression is now being used as a surrogate marker of HPV infection in squamous cell carcinoma and provides important prognostic information and future therapy planning. Materials and Methods: In this prospective study, total of 75 cases of HNSCC were taken. Tumor grade was determined according to World Health Organization (WHO) criteria. p16 expression was determined by immunohistochemical staining. The obtained results were analyzed and evaluated using Chi-square test (Statistical Package for Social Sciences (SPSS) version 20), value of P Results: Out of 75 cases, 78.7% cases were positive for p16 (inclusive of all grades), while 21.3% cases were negative. Expression of p16 was higher in nonsmokers and nonalcohol consumers and significantly associated with paan chewing habit. No significant correlation was seen with history of abnormal sexual habits, but p16 expression was significantly correlated in cases with multiple sexual partners (P = 0.003), with increasing histological grade (P = 0.045) and in cases with lymph node metastasis (P = 0.03). Conclusion: As HPV integration with transcription of viral oncoprotein induces overexpression of p16, immunohistochemical expression of p16 can be used as a surrogate marker of HPV. This approach can be implemented in diagnostic laboratories and can provide support for vaccination program in high risk group.
机译:简介:口腔鳞状细胞癌是整个发达国家的主要死亡原因。它与吸烟和饮酒有关。还已建议16型人乳头瘤病毒(HPV)在头颈部鳞状细胞癌(HNSCC)的病因中起作用。现在p16表达被用作鳞状细胞癌HPV感染的替代标志物,并提供重要的预后信息和未来治疗计划。资料与方法:在这项前瞻性研究中,共纳入了75例HNSCC病例。根据世界卫生组织(WHO)的标准确定肿瘤等级。通过免疫组织化学染色确定p16表达。使用卡方检验(社会科学统计软件包(SPSS)版本20)对获得的结果进行分析和评估,P值为P结果:在75例病例中,p16阳性(包括所有年级)为78.7%,而21.3%的病例为阴性。非吸烟者和非饮酒者中p16的表达较高,并且与咀嚼习惯密切相关。与异常性生活史无显着相关性,但在有多个性伴侣的情况下(p = 0.003),组织学分级增加(P = 0.045)和有淋巴结转移的情况(P = 0.03),p16表达显着相关。 )。结论:由于HPV整合和病毒癌蛋白转录诱导p16的过度表达,p16的免疫组织化学表达可作为HPV的替代标志物。这种方法可以在诊断实验室中实施,并且可以为高危人群的疫苗接种计划提供支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号